Meet Ingemar Kihlstörm - facilitating the next stage of growth

Financing innovations in pharmaceutical development – facilitating the next stage of growth

Operational Report Q3 2020

Meet Margareth Jorvid leading innovations to products

Some thoughts from the CEO

Operational Report Q2 2020

High level operational report summarising key milestones Q2 2020 and forward looking statement.

Ilya Pharma awarded risk-shared funding by EIT Health

Ilya Pharma awarded Euros 5.3 million from EIC Accelerator to fast track Phase II study of first-in-class ILPI100 advanced therapy for wound treatment in people with diabetes

4000 applicants, 72 SMEs awarded, Ilya Pharmas project among the 1.8 % winners!

Resuming recruitment to the ongoing clinical trial - final cohorts

Operational Report Q1 2020

COVID-19 operations impact